To further explore miR-520b and PTEN role in breast cancer, we first used the Starbase to predict the binding site and dual-luciferase reporter assay to prove the binding of miR-520b to PTEN (Figures 3(a) and 3(b)). Here, PTEN is linked to breast carcinoma.